• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Unichemlab Share Price

    Unichem Laboratories Share PriceUnichem Laboratories

    Small Cap 5k Result
    ₹419.7
    0.85 (0.2%)
    As on 04 December, 2023 | 21:14 BSE: 506690 NSE: UNICHEMLABISIN: INE351A01035

    Unichem Laboratories Performance

    Day Range

    • Low 417.00
    • High 430.80
    ₹ 419.7

    52 Week Range

    • Low 264.80
    • High 455.00
    ₹ 419.7
    • Open Price430.80
    • Previous Close418.85
    • Volume21115

    Start SIP in Unichem Laboratories

    Start SIP

    Unichem Laboratories Share Price

    • Over 1 Month 4.72%
    • Over 3 Month 0.58%
    • Over 6 Month 13.04%
    • Over 1 Year 13.83%

    Unichem Laboratories Key Statistics

    P/E Ratio -22.2
    PEG Ratio 0.1
    Market Cap Cr 2,955
    Price to Book Ratio 1.2
    EPS -27.9
    Dividend 0
    Relative Strength Index 51.09
    Money Flow Index 74.43
    MACD Signal 0.15
    Average True Range 12.8

    Unichem Laboratories Investment Rating

    • Master Rating:

    • Unichem Laboratories has an operating revenue of Rs. 1,543.41 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of -10% needs improvement, ROE of -8% is poor and needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 43 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Unichem Laboratories Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 334347310252266245277
    Operating Expenses Qtr Cr 341338319294297256264
    Operating Profit Qtr Cr -78-9-42-31-1112
    Depreciation Qtr Cr 27272829262321
    Interest Qtr Cr 4232321
    Tax Qtr Cr 0000210-18
    Net Profit Qtr Cr -31-16-144-57-75-2317
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,114985
    Operating Expenses Annual Cr 1,165986
    Operating Profit Annual in Cr -93-44
    Depreciation Cr 10683
    Interest Annual Cr 92
    Tax Annual Cr 21-31
    Net Profit Annual Cr -300-55
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -117-158
    Cash from Investing Activity Annual Cr 202104
    Cash from Financing Annual Activity Cr -6296
    Net Cash Flow Annual Cr 2342
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2,3842,672
    Fixed Assets Annual Cr 1,3841,457
    Total Non Current Assets Annual Cr 1,5901,748
    Total Current Assets Annual Cr 1,2961,374
    Total Assets Annual Cr 2,8863,122
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 339380
    ROE Annual % -13-2
    ROCE Annual % -6-3
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -50
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 416423402302329310370
    Operating Expenses Qtr Cr 407395386345347311302
    Operating Profit Qtr Cr 92816-43-18-168
    Depreciation Qtr Cr 29293031282523
    Interest Qtr Cr 7664532
    Tax Qtr Cr 33-33233-14
    Net Profit Qtr Cr -24-1-44-64-71-2371
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,3821,317
    Operating Expenses Annual Cr 1,3891,197
    Operating Profit Annual in Cr -4673
    Depreciation Cr 11391
    Interest Annual Cr 176
    Tax Annual Cr 26-11
    Net Profit Annual Cr -20233
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -85-260
    Cash from Investing Activity Annual Cr 203100
    Cash from Financing Annual Activity Cr -81191
    Net Cash Flow Annual Cr 3632
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 2,4352,618
    Fixed Assets Annual Cr 1,4031,482
    Total Non Current Assets Annual Cr 1,6011,670
    Total Current Assets Annual Cr 1,5921,648
    Total Assets Annual Cr 3,1933,319
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 346372
    ROE Annual % -81
    ROCE Annual % -51
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % -19
    Invest in Unichem Laboratories

    Unichem Laboratories Technicals

    EMA & SMA

    Current Price
    ₹419.7
    0.85 (0.2%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹418.59
    • 50 Day
    • ₹416.60
    • 100 Day
    • ₹407.39
    • 200 Day
    • ₹387.19
    • 20 Day
    • ₹415.87
    • 50 Day
    • ₹418.61
    • 100 Day
    • ₹410.41
    • 200 Day
    • ₹378.95

    Unichem Laboratories Resistance and Support

    PIVOT
    ₹422.5
    Resistance
    First Resistance 428.00
    Second Resistance 436.30
    Third Resistance 441.80
    RSI 51.09
    MFI 74.43
    MACD Single Line 0.15
    MACD 0.45
    Support
    First Resistance 414.20
    Second Resistance 408.70
    Third Resistance 400.40

    Unichem Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 21,947 1,439,504 65.59
    Week 14,999 990,971 66.07
    1 Month 24,226 1,123,830 46.39
    6 Month 137,250 9,225,962 67.22

    Unichem Laboratories Result Highlights

    Unichem Laboratories Synopsis

    NSE-Medical-Diversified

    Unichem Labs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1072.43 Cr. and Equity Capital is Rs. 14.08 Cr. for the Year ended 31/03/2023. Unichem Laboratories Ltd. is a Public Limited Listed company incorporated on 22/08/1962 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1962PLC012451 and registration number is 012451.
    Market Cap 2,936
    Sales 1,243
    Shares in Float 2.11
    No of funds 41
    Yield 0.73
    Book Value 1.24
    U/D Vol ratio 0.8
    LTDebt / Equity 3
    Alpha 0.03
    Beta 1.09

    Unichem Laboratories

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 70.21%50.93%50.93%50.93%
    Mutual Funds 8.56%6.11%6.69%6.78%
    Insurance Companies 0.23%1.11%0.23%0.23%
    Foreign Portfolio Investors 0.83%1.62%1.7%1.56%
    Financial Institutions/ Banks 0.03%0.18%0.03%0.04%
    Individual Investors 15.8%26.86%30.91%30.99%
    Others 4.34%13.19%9.51%9.47%

    Unichem Laboratories Management

    Name Designation
    Dr. Prakash A Mody Chairman, Non Ind & Non Exe Director
    Mr. Pabitrakumar Kalipada Bhattacharyya Managing Director
    Mr. Pranay Premchand Godha Non Exe.Non Ind.Director
    Ms. Priti Puri Independent Director
    Mr. Prafull Sheth Independent Director
    Mr. Anand Mahajan Independent Director
    Mr. Prafull Anubhai Independent Director

    Unichem Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Unichem Laboratories Corporate Action

    Date Purpose Remarks
    2023-11-01 Quarterly Results
    2023-07-14 Quarterly Results
    2023-05-23 Audited Results
    2023-02-06 Quarterly Results
    2022-11-11 Quarterly Results

    Unichem Laboratories MF Shareholding

    Name Amount(cr)
    HDFC Small Cap Fund Growth 23,184
    DSP Healthcare Fund Regular Growth 1,718
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
    Groww Nifty Total Market Index Fund Regular Growth 32
    Motilal Oswal S&P BSE Healthcare ETF 8

    Unichem Laboratories FAQs

    What is Share Price of Unichem Laboratories ?

    Unichem Laboratories share price is ₹419 As on 04 December, 2023 | 21:00

    What is the Market Cap of Unichem Laboratories ?

    The Market Cap of Unichem Laboratories is ₹2954.9 Cr As on 04 December, 2023 | 21:00

    What is the P/E ratio of Unichem Laboratories ?

    The P/E ratio of Unichem Laboratories is -22.2 As on 04 December, 2023 | 21:00

    What is the PB ratio of Unichem Laboratories ?

    The PB ratio of Unichem Laboratories is 1.2 As on 04 December, 2023 | 21:00

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.